株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

セルベースアッセイの世界市場の予測 〜2020年:製品・用途 (研究・創薬・ADME研究・毒物学)・エンドユーザー・地域別

Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 301568
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
セルベースアッセイの世界市場の予測 〜2020年:製品・用途 (研究・創薬・ADME研究・毒物学)・エンドユーザー・地域別 Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020
出版日: 2015年11月03日 ページ情報: 英文 179 Pages
概要

世界のセルベースアッセイ市場は2015年から2020年にかけて11.16%のCAGRで推移し、2015年の107億9953万米ドルから、2020年には183億2937万米ドルの規模に成長すると予測されています。2015年の用途別シェアでは創薬部門が最大のシェアを記録し、2015年から2020年にかけての予測期間中は毒性予測が最速成長の部門のひとつとなる見込みです。

当レポートでは、世界のセルベースアッセイの市場について調査し、市場を構成する製品・サービスの種類と概要、市場成長への各種影響因子および市場機会の分析、製品・用途・地域別の市場動向および市場規模の推移と予測、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 大きな市場機会
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 製品別
    • 用途別
    • エンドユーザー別
  • 市場力学
    • 推進因子
    • 阻害因子
    • 市場機会
    • 動向

第6章 市場分析:製品別

  • イントロダクション
  • 消耗品
    • 試薬・アッセイキット
      • レポーター遺伝子アッセイ
      • セカンドメッセンジャーアッセイ
      • 細胞増殖アッセイ
      • 細胞死アッセイ
      • その他
    • マイクロプレート
    • 細胞系
      • 不死化細胞系
      • 初代細胞系
      • 幹細胞系
    • その他
  • 機器
  • サービス
  • ソフトウェア

第7章 市場分析:用途別

  • イントロダクション
  • 創薬
  • 基礎研究
  • ADME研究
  • 毒性予測
  • その他

第8章 市場分析:エンドユーザー別

  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 学術機関・政府機関
  • CRO
  • その他

第9章 市場分析:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア
  • その他

第10章 競合環境

  • イントロダクション
  • 戦略概要
  • 市場シェア分析
  • 競合状況・動向
    • 新製品の投入
    • 買収
    • 協力・合意
    • 拡張
    • その他

第11章 COMPANY PROFILES

  • イントロダクション
  • BECTON, DICKINSON AND COMPANY
  • CELL SIGNALING TECHNOLOGY, INC.
  • CISBIO BIOASSAYS
  • DANAHER CORPORATION
  • DISCOVERX CORPORATION
  • GENERAL ELECTRIC COMPANY
  • MERCK & CO., INC.
  • PERKINELMER, INC.
  • PROMEGA CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
    • 財務動向
    • 製品・サービス
    • 主要戦略
    • 近年の発展動向、など

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2486

The global cell-based assays market is expected to reach USD 18,329.37 million by 2020 from USD 10,799.53 million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. The product segments included in this report are consumables, instruments, services and software. The consumables segment is further divided on the basis of type into reagents and assay kits, cell lines, micro plates. Reagents and assay kits segment is further divided into reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays. Cell lines segment is further classified into immortalized cell lines, primary cell lines and stem cell lines. On the basis of applications; the report is segmented into basic research, drug discovery, predictive toxicology, ADME studies and other applications. The drug discovery had the largest share of the cell-based assays market in 2015. The predictive toxicology is expected to be one of the fastest growing applications between 2015 and 2020.

The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global cell-based assays market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020.

The key driver for this market is increased R&D spending on research. Furthermore, growing benefits of cell-based assays over other methods, their increasing adoption in drug discovery, and advancements in automation and high-throughput techniques will aid market growth.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global cell-based assays market and its sub-segments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their cell-based assays product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each sub segment and the relative differences in the growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important sub segments. It maps the market sizes and growth rates of each sub segment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the cell-based assays market. The competitive landscape covers the growth strategies adopted by the industry players over the last four years. It also includes analysis of industry developments like new product launches, expansions, agreements and collaborations and acquisitions.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development: Product portfolios of the top players in the cell-based assays market.
  • Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the cell-based assays market.
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various cell-based assays products across geographies.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LUCRATIVE OPPORTUNITIES IN THE CELL-BASED ASSAYS MARKET
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. BY PRODUCT
    • 5.1.2. BY APPLICATION
    • 5.1.3. BY END USER
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increase in R&D investments
      • 5.2.1.2. Government funding and public-private partnerships supporting cell-based research activities
      • 5.2.1.3. Advantages of cell-based assays over prevalent technologies
      • 5.2.1.4. Drug discovery, a major driver for the cell-based assays market
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High instrument costs
      • 5.2.2.2. Stringent regulatory policies
      • 5.2.2.3. Intellectual property rights issues restricting innovations in the market
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Asian region offers high-growth opportunities
      • 5.2.3.2. Developments in high-content screening and software to transform cell-based screening
    • 5.2.4. TRENDS
      • 5.2.4.1. Label-free technologies are set to transform the market

6. CELL-BASED ASSAYS MARKET, BY PRODUCT 46

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. REAGENTS & ASSAY KITS
      • 6.2.1.1. Reporter gene assays
      • 6.2.1.2. Second messenger assays
      • 6.2.1.3. Cell growth assays
      • 6.2.1.4. Cell death assays
      • 6.2.1.5. Other assays
    • 6.2.2. MICROPLATES
    • 6.2.3. CELL LINES
      • 6.2.3.1. Immortalized cell lines
      • 6.2.3.2. Primary cell lines
      • 6.2.3.3. Stem cell lines
    • 6.2.4. OTHER CONSUMABLES
  • 6.3. INSTRUMENTS
  • 6.4. SERVICES
  • 6.5. SOFTWARE

7. CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. DRUG DISCOVERY
  • 7.3. BASIC RESEARCH
  • 7.4. ADME STUDIES
  • 7.5. PREDICTIVE TOXICOLOGY
  • 7.6. OTHER APPLICATIONS

8. CELL-BASED ASSAYS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.3. ACADEMIC & GOVERNMENT INSTITUTIONS
  • 8.4. CONTRACT RESEARCH ORGANIZATIONS
  • 8.5. OTHER END USERS

9. CELL-BASED ASSAYS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. STRATEGIC OVERVIEW
  • 10.3. MARKET SHARE ANALYSIS
  • 10.4. COMPETITIVE SITUATION AND TRENDS
    • 10.4.1. NEW PRODUCT LAUNCHES
    • 10.4.2. ACQUISITIONS
    • 10.4.3. COLLABORATIONS AND AGREEMENTS
    • 10.4.4. EXPANSIONS
    • 10.4.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 11.1. INTRODUCTION
  • 11.2. BECTON, DICKINSON AND COMPANY
  • 11.3. CELL SIGNALING TECHNOLOGY, INC.
  • 11.4. CISBIO BIOASSAYS
  • 11.5. DANAHER CORPORATION
  • 11.6. DISCOVERX CORPORATION
  • 11.7. GENERAL ELECTRIC COMPANY
  • 11.8. MERCK KGAA
  • 11.9. PERKINELMER, INC.
  • 11.10. PROMEGA CORPORATION
  • 11.11. THERMO FISHER SCIENTIFIC, INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: CELL-BASED ASSAYS MARKET SUMMARY
  • TABLE 2: INCREASING HEALTHCARE EXPENDITURE: THE PRIMARY DRIVER FOR THE GROWTH OF THE CELL-BASED ASSAYS MARKET
  • TABLE 3: MARKET GROWTH RESTRAINED BY HIGH INSTRUMENT COSTS
  • TABLE 4: EMERGING ECONOMIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 5: LABEL-FREE TECHNOLOGIES ARE AN IMPORTANT MARKET TREND
  • TABLE 6: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 7: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 9: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: CELL-BASED ASSAYS MARKET FOR REAGENTS & ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 11: CELL-BASED ASSAYS MARKET SIZE FOR REPORTER GENE ASSAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: CELL-BASED ASSAYS MARKET SIZE FOR SECOND MESSENGER ASSAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: CELL-BASED ASSAYS MARKET SIZE FOR CELL GROWTH ASSAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: CELL-BASED ASSAYS MARKET SIZE FOR CELL DEATH ASSAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: CELL-BASED ASSAYS MARKET SIZE FOR OTHER ASSAYS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: CELL-BASED ASSAYS MARKET SIZE FOR MICROPLATES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: CELL-BASED ASSAYS MARKET SIZE FOR CELL LINES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 19: CELL-BASED ASSAYS MARKET SIZE FOR IMMORTALIZED CELL LINES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: CELL-BASED ASSAYS MARKET SIZE FOR PRIMARY CELL LINES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: CELL-BASED ASSAYS MARKET SIZE FOR STEM CELL LINES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: CELL-BASED ASSAYS MARKET SIZE FOR OTHER CONSUMABLES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: CELL-BASED ASSAYS MARKET SIZE FOR INSTRUMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: CELL-BASED ASSAYS MARKET SIZE FOR SERVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: CELL-BASED ASSAYS MARKET SIZE FOR SOFTWARE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 27: CELL-BASED ASSAYS MARKET SIZE FOR DRUG DISCOVERY APPLICATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: CELL-BASED ASSAYS MARKET SIZE FOR BASIC RESEARCH APPLICATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: CELL-BASED ASSAYS MARKET SIZE FOR ADME STUDIES APPLICATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: CELL-BASED ASSAYS MARKET SIZE FOR PREDICTIVE TOXICOLOGY APPLICATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: CELL-BASED ASSAYS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 33: CELL-BASED ASSAYS MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: CELL-BASED ASSAYS MARKET SIZE FOR ACADEMIC & GOVERNMENT INSTITUTIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: CELL-BASED ASSAYS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: CELL-BASED ASSAYS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: CELL-BASED ASSAYS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 44: U.S.: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 45: U.S.: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: U.S.: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 47: U.S.: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 48: U.S.: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 49: CANADA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 50: CANADA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 51: CANADA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: CANADA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 53: CANADA: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: CELL-BASED ASSAYS MARKET FOR REAGENTS & ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 58: EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 63: ASIA: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 69: MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND SEPTEMBER 2015
  • TABLE 70: NEW PRODUCT LAUNCHES, JAUNARY 2013 TO SEPTEMBER 2015
  • TABLE 71: ACQUISITIONS, JAUNARY 2013 TO SEPTEMBER 2015
  • TABLE 72: COLLABORATIONS AND AGREEMENTS, JAUNARY 2013 TO SEPTEMBER 2015
  • TABLE 73: EXPANSIONS, JAUNARY 2013 TO SEPTEMBER 2015
  • TABLE 74: OTHER DEVELOPMENTS, JAUNARY 2013 TO SEPTEMBER 2015

LIST OF FIGURES

  • FIGURE 1: CELL-BASED ASSAYS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: CONSUMABLES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: REAGENTS & KITS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: CELL LINES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 11: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 12: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 13: CELL-BASED ASSAYS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 14: GLOBAL CELL-BASED ASSAYS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES END-USER SEGMENT TO DOMINATE THE CELL-BASED ASSAYS MARKET
  • FIGURE 16: ASIA TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 17: ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 18: CELL-BASED ASSAYS MARKET SEGMENTATION: BY PRODUCT
  • FIGURE 19: CELL-BASED ASSAYS MARKET SEGMENTATION: BY APPLICATION
  • FIGURE 20: CELL-BASED ASSAYS MARKET SEGMENTATION: BY END USER
  • FIGURE 21: INCREASING R&D SPENDING WILL DRIVE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: INCREASING R&D INVESTMENTS BOOSTING GROWTH IN THE CELL-BASED ASSAYS MARKET
  • FIGURE 23: CELL-BASED ASSAYS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 24: CELL-BASED ASSAYS MARKET, BY PRODUCT, 2015 (USD MILLION)
  • FIGURE 25: NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE CONSUMABLES MARKET IN 2015
  • FIGURE 26: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 27: CELL-BASED ASSAYS MARKET FOR REAGENTS & ASSAY KITS, BY TYPE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 28: NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE INSTRUMENTS MARKET IN 2015
  • FIGURE 29: NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE SERVICES MARKET IN 2015
  • FIGURE 30: NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE SOFTWARE MARKET IN 2015
  • FIGURE 31: CELL-BASED ASSAYS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 32: DRUG DISCOVERY ACCOUNTS FOR THE LARGEST APPLICATION SEGMENT OF THE CELL-BASED ASSAYS MARKET IN 2015
  • FIGURE 33: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE DRUG DISCOVERY APPLICATION SEGMENT IN 2015
  • FIGURE 34: NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATION IN 2015
  • FIGURE 35: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ADME STUDIES APPLICATION SEGMENT IN 2015
  • FIGURE 36: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PREDICTIVE TOXICOLOGY APPLICATION SEGMENT IN 2015
  • FIGURE 37: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE OTHER APPLICATIONS SEGMENT IN 2015
  • FIGURE 38: CELL-BASED ASSAYS MARKET SEGMENTATION, BY END USER
  • FIGURE 39: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015 (USD MILLION)
  • FIGURE 40: NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN 2015
  • FIGURE 41: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTIONS TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2015 AND 2020
  • FIGURE 42: NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020
  • FIGURE 43: CELL-BASED ASSAYS MARKET FOR OTHER END USERS TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2015 AND 2020
  • FIGURE 44: ASIA TO GROW AT THE HIGHEST RATE IN THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 45: GEOGRAPHIC SNAPSHOT (2015)
  • FIGURE 46: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 47: THE U.S. IS ESTIMATED TO DOMINATE THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2015
  • FIGURE 48: CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2015
  • FIGURE 49: REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN THE NORTH AMERICAN CONSUMABLES MARKET IN 2015
  • FIGURE 50: REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN THE NORTH AMERICAN REAGENTS & ASSAY KITS MARKET IN 2015
  • FIGURE 51: DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF THE APPLICATION MARKET IN NORTH AMERICA IN 2015
  • FIGURE 52: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN NORTH AMERICA
  • FIGURE 53: CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE U.S. CELL-BASED ASSAYS MARKET IN 2015
  • FIGURE 54: REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN THE U.S. CONSUMABLES MARKET IN 2015
  • FIGURE 55: REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN THE U.S. REAGENTS & ASSAY KITS MARKET IN 2015
  • FIGURE 56: DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF THE U.S. CELL-BASED ASSAYS MARKET IN 2015
  • FIGURE 57: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN THE U.S.
  • FIGURE 58: CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE CELL-BASED ASSAYS MARKET IN CANADA IN 2015
  • FIGURE 59: REAGENTS & ASSAYS KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE CONSUMABLES MARKET IN CANADA IN 2015
  • FIGURE 60: REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE REAGENTS & ASSAY KITS MARKET IN CANADA IN 2015
  • FIGURE 61: DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF THE CELL-BASED ASSAYS MARKET IN CANADA IN 2015
  • FIGURE 62: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN CANADA
  • FIGURE 63: CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN CELL-BASED ASSAYS MARKET IN 2015
  • FIGURE 64: REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN THE EUROPEAN CONSUMABLES MARKET IN 2015
  • FIGURE 65: REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN THE EUROPEAN REAGENTS & ASSAY KITS MARKET IN 2015
  • FIGURE 66: DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS APPLICATION MARKET IN EUROPE IN 2015
  • FIGURE 67: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS END-USER MARKET IN EUROPE
  • FIGURE 68: ASIA: MARKET SNAPSHOT
  • FIGURE 69: CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ASIAN MARKET IN 2015
  • FIGURE 70: REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN THE ASIAN CONSUMABLES MARKET IN 2015
  • FIGURE 71: REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN THE ASIAN REAGENTS & ASSAY KITS MARKET IN 2015
  • FIGURE 72: DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS APPLICATIONS MARKET IN ASIA IN 2015
  • FIGURE 73: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS END-USER MARKET IN ASIA
  • FIGURE 74: CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW CELL-BASED ASSAYS MARKET IN 2015
  • FIGURE 75: REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN THE ROW CONSUMABLES MARKET IN 2015
  • FIGURE 76: REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN THE ROW REAGENTS & ASSAY KITS MARKET IN 2015
  • FIGURE 77: DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW CELL-BASED ASSAYS APPLICATIONS MARKET IN 2015
  • FIGURE 78: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW CELL-BASED ASSAYS END-USER MARKET
  • FIGURE 79: NEW PRODUCTS LAUNCHES IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE CELL-BASED ASSAYS MARKET
  • FIGURE 80: CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 81: FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
  • FIGURE 82: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 83: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 84: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • FIGURE 85: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 86: PERKINELMER, INC.: COMPANY SNAPSHOT
  • FIGURE 87: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
Back to Top